The Prognostic Value of Serum Levels of Heart-Type Fatty Acid Binding Protein and High Sensitivity C-Reactive Protein in Patients With Increased Levels of Amino-Terminal Pro-B Type Natriuretic Peptide
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Amino-terminal pro-B type natriuretic peptide (NT-proBNP) is a well-established prognostic factor in heart failure (HF). However, numerous causes may lead to elevations in NT-proBNP, and thus, an increased NT-proBNP level alone is not sufficient to predict outcome. The aim of this study was to evaluate the utility of two acute response markers, high sensitivity C-reactive protein (hsCRP) and heart-type fatty acid binding protein (H-FABP), in patients with an increased NT-proBNP level. Methods: The 278 patients were classified into three groups by etiology: 1) acute coronary syndrome (ACS) (n=62), 2) non-ACS cardiac disease (n=156), and 3) infectious disease (n=60). Survival was determined on day 1, 7, 14, 21, 28, 60, 90, 120, and 150 after enrollment. Results: H-FABP (P<0.001), NT-proBNP (P=0.006), hsCRP (P<0.001) levels, and survival (P<0.001) were significantly different in the three disease groups. Patients were divided into three classes by using receiver operating characteristic curves for NT-proBNP, H-FABP, and hsCRP. Patients with elevated NT-proBNP (≥3,856 pg/mL) and H-FABP (≥8.8 ng/mL) levels were associated with higher hazard ratio for mortality (5.15 in NT-proBNP and 3.25 in H-FABP). Area under the receiver operating characteristic curve analysis showed H-FABP was a better predictor of 60-day mortality than NT-proBNP. Conclusions: The combined measurement of H-FABP with NT-proBNP provides a highly reliable means of short-term mortality prediction for patients hospitalized for ACS, non-ACS cardiac disease, or infectious disease.
Abstract
Background: Amino-terminal pro-B type natriuretic peptide (NT-proBNP) is a well-established prognostic factor in heart failure (HF). However, numerous causes may lead to elevations in NT-proBNP, and thus, an increased NT-proBNP level alone is not sufficient to predict outcome. The aim of this study was to evaluate the utility of two acute response markers, high sensitivity C-reactive protein (hsCRP) and heart-type fatty acid binding protein (H-FABP), in patients with an increased NT-proBNP level. Methods: The 278 patients were classified into three groups by etiology: 1) acute coronary syndrome (ACS) (n=62), 2) non-ACS cardiac disease (n=156), and 3) infectious disease (n=60). Survival was determined on day 1, 7, 14, 21, 28, 60, 90, 120, and 150 after enrollment. Results: H-FABP (P<0.001), NT-proBNP (P=0.006), hsCRP (P<0.001) levels, and survival (P<0.001) were significantly different in the three disease groups. Patients were divided into three classes by using receiver operating characteristic curves for NT-proBNP, H-FABP, and hsCRP. Patients with elevated NT-proBNP (≥3,856 pg/mL) and H-FABP (≥8.8 ng/mL) levels were associated with higher hazard ratio for mortality (5.15 in NT-proBNP and 3.25 in H-FABP). Area under the receiver operating characteristic curve analysis showed H-FABP was a better predictor of 60-day mortality than NT-proBNP. Conclusions: The combined measurement of H-FABP with NT-proBNP provides a highly reliable means of short-term mortality prediction for patients hospitalized for ACS, non-ACS cardiac disease, or infectious disease.
참고문헌 (22)
- Baggish AL, "Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure", Am J Cardiol, 101, pp.49~55 (2008)
- Doust JA, "A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure", Arch Intern Med, 164, pp.1978~1984 (2004)
- Mathewkutty S, "Biomarkers after risk stratification in acute chest pain (from the BRIC Study)", Am J Cardiol, 111, pp.493~498 (2013)
- Eric Christenson, "The Role of Cardiac Biomarkers in the Diagnosis and Management of Patients Presenting with Suspected Acute Coronary Syndrome", Annals of Laboratory Medicine, 33(5), pp.309~318 (2013), 대한진단검사의학회
- Ray P, "Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department", QJM, 101, pp.831~843 (2008)
- Lindahl B, "Acute coronary syndrome-the present and future role of biomarkers", Clin Chem Lab Med, 51, pp.1699~1706 (2013)
- Kim H, "Incremental prognostic value of C-reactive protein and N-terminal proB-type natriuretic peptide in acute coronary syndrome", Circ J, 70, pp.1379~1384 (2006)
- Windram JD, "Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure", Am Heart J, 153, pp.1048~1055 (2007)
- Offner GD, "Characterization and amino acid sequence of a fatty acid-binding protein from human heart", Biochem J, 252, pp.191~198 (1988)
- Glatz JF, "Cellular fatty acid-binding proteins: their function and physiological significance", Prog Lipid Res, 35, pp.243~282 (1996)
- Lippi G, "Critical review and meta-analysis on the combination of heart-type fatty acid binding protein (H-FABP) and troponin for early diagnosis of acute myocardial infarction", Clin Biochem, 46, pp.26~30 (2013)
- Komamura K, "Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy", Heart, 92, pp.615~618 (2006)
- Liao J, "Human heart-type fatty acid-binding protein for on-site diagnosis of early acute myocardial infarction", Int J Cardiol, 133, pp.420~423 (2009)
- Okamoto F, "Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB", Clin Chem Lab Med, 38, pp.231~238 (2000)
- DeLong ER, "Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach", Biometrics, 44, pp.837~845 (1988)
- Viswanathan K, "Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative", J Am Coll Cardiol, 55, pp.2590~2598 (2010)
- Jo YH, "Heart-type fatty acid-binding protein as a prognostic factor in patients with severe sepsis and septic shock", Am J Emerg Med, 30, pp.1749~1755 (2012)
- Lagrand WK, "C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?", Circulation, 100, pp.96~102 (1999)
- Ridker PM, "Clinical application of C-reactive protein for cardiovascular disease detection and prevention", Circulation, 107, pp.363~369 (2003)
- Silvestre J, "Is C-reactive protein a good prognostic marker in septic patients?", Intensive Care Med, 35, pp.909~913 (2009)
- Müller B, "Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia", BMC Infect Dis, 7, pp.10~ (2007)
- Krüger S, "Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes", Eur Respir J, 31, pp.349~355 (2008)